Catalyst Wire Dossier Catalyst Wire Dossier

Respimat Soft Mist Inhaler

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Respimat Soft Mist Inhaler, covering 2021-03-03 to 2021-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Re-usable Respimat® Soft MistTM Inhaler Study

See pricing